Here’s Our Take On Neurocrine Biosciences, Inc. (NBIX)'s Ingrezza
Neurocrine Biosciences, Inc.
Neurocrine Biosciences Inc (NBIX)
Market is closed
News
- First
- << Previous
- 71 - 80
- Next >>
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks
Founded by Paul Sinclair in August 2014, Blue Jay Capital Management is a healthcare-focused hedge fund based in California.
Top Biotech Picks of Best-Performing Hedge Fund of 2015
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top of the list was biotech-focused hedge fund Perceptive...
Four Stocks Driving Thursday’s Market Gains: How Did They Do It?
In the first eight days of the year, the S&P 500 index fell by roughly 7.5%, the Dow lost 7.3%, and the NASDAQ tumbled by 9.6%.
Hedge Funds Growing Fond Of Neurocrine Biosciences, Inc. (NBIX)
Is Neurocrine Biosciences, Inc. (NASDAQ:NBIX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
Amicus Therapeutics, Inc. (FOLD), Neurocrine Biosciences, Inc. (NBIX), and Retrophin Inc (RTRX) among Biotech Guru Joseph Edelman's Top Healthcare Picks
Biotech Guru Joseph Edelman's Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks.
More Than 60% Returns For These Two Hedgies' Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds, namely James A.
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading activity.
Neurocrine Biosciences, Inc. (NBIX), ChemoCentryx Inc (CCXI), Avanir Pharmaceuticals, Inc. (AVNR): Horrendous Health-Care Stocks Last Week
In a way, stocks go through seasons like the weather. Sometimes they spring forth, sometimes they're hot like summer, sometimes they're dormant and cold like winter. And sometimes they just fall.
GlaxoSmithKline plc (ADR) (GSK), Inovio Pharmaceuticals Inc (INO), ISIS Pharmaceuticals, Inc. (ISIS): This Week in Biotech
With the SPDR S&P Biotech Index up 40% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
- First
- << Previous
- 71 - 80
- Next >>
Billionaire Hedge Funds
